BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Hematopoietic cell
,
Phenobarbital
,
rs2230926
,
FOXP1
,
Coagulation
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PFKFB3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Kidney medulla
Omental adipose tissue
Adipose tissue subcutaneous
Adipose tissue
Leukocyte (polymorphonuclear) of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Immunoglobulin G4 deficiency
Shock
Muscle atrophy
Hemorrhagic shock
Anthrax
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
IL21 protein, human
COOH-terminal signal transamidase
HX 630
marimastat
Nifurtimox
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
PABPN1
RSU1
HSPA1B
CLCN1
ACTA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
PFKFB3 downregulation aggravates Angiotensin II-induced podocyte detachment.
Overexpression of PFKFB3 promotes cell glycolysis and proliferation in renal cell carcinoma.
Differential role of neuronal glucose and PFKFB3 in memory formation during development.
Gene-dosage effect of Pfkfb3 on monocyte/macrophage biology in atherosclerosis.
Upregulation of glycolytic enzyme PFKFB3 by deubiquitinase OTUD4 promotes cardiac fibrosis post myoc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ